AMIE WILCOX: Open Payments
NPI 1699364505 · SILVERDALE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,753 in 82 payments from 23 companies in 2025. Trend: 2023 $2,153 · 2024 $2,766 · 2025 $2,753
Food & beverage: $2,753
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $366 |
| Alnylam Pharmaceuticals Inc. | 6 | $232 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $229 |
| SCPHARMACEUTICALS INC. | 3 | $189 |
| Novo Nordisk Inc | 4 | $183 |
| Esperion Therapeutics, Inc. | 9 | $171 |
| Abbott Laboratories | 1 | $166 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $152 |
| Novartis Pharmaceuticals Corporation | 7 | $140 |
| Edwards Lifesciences Corporation | 1 | $135 |
Products named: Kerendia, BREZTRI, AMVUTTRA, FUROSCIX, NEXLETOL, MITRACLIP, LifeVest, LEQVIO.
Industry payments across WA — which companies pay providers there.
